Article

Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniques

2020-05-20

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Breast cancer has common tumor biological characteristics, but different characteristics also exist among different subtypes. Different treatment strategies have been adopted for different subtypes at present, but there are still many problems. Thus, an-depth study on the heterogeneity of different types of breast cancer will help to identify new diagnostic ther...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2b828a6a-ffd8-5ff8-b1aa-350479e932b2
DOI: 10.21203/rs.3.rs-27419/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniquesDOI 10.21203/rs.3.rs-27419/v1Read

Bioinformatics for differential proteomics data between triple-negative breast cancer and luminal A subtype breast cancerSemantic proximity Read

Characterizing the Relapse Potential in Different Luminal Subtypes of Breast Cancers with Functional ProteomicsSemantic proximity Read

Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancerSemantic proximity Read

Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancerSemantic proximity Read

Quantitative Proteomics of Breast Benign and Malignant Tumors Reveals a Malignancy SignatureSemantic proximity Read

Identification of key genes unique to the luminal A and basal-like breast cancer subtypes via bioinformatic analysisSemantic proximity Read

Comprehensive proteome and phosphoproteome analysis reveals the protein characterization of invasive ductal and lobular carcinoma with specific molecular subgroupSemantic proximity Read

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity Read

Coupling proteomics and transcriptomics in the quest of subtype‐specific proteins in breast cancerSemantic proximity Read

Prediction of breast cancer proteins using molecular descriptors and artificial neural networks: a focus on cancer immunotherapy proteins, metastasis driver proteins, and RNA-binding proteinsSemantic proximity Read

ECM Remodeling in Breast Cancer with Different Grade: Contribution of 2D‐DIGE ProteomicsSemantic proximity Read

Comparative proteomic analysis in human and canine breast cancer cell line: identification of proteins linked to lipid dynamics and functionsSemantic proximity Read